Kadimastem - Stem Cell to Cure Diseases
  • Robust Stem Cell
    Expansion Technologies

  • Diverse Stem Cell
    Differentiation Capabilities

  • Highly Sensitive Drug
    Screening Platform

  • Promising Therapeutic Programs

Stem Cell to Cure Diseases

Kadimastem (TASE:KDST) is a leading regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders.

The company’s proprietary technologies and know-how enable the differentiation of stem cells into insulin secreting beta cells as well as a range of neural cells (Oligodendrocytes, Astrocytes).  

Based on its platform technologies, Kadimastem is advancing two therapeutic programs in diabetes mellitus and ALS, and, in addition, Kadimastem is partnering with pharmaceutical companies interested to screen (hit-lead, lead optimization) potential drug compounds on its stem-cell derived cells. 

News & Events